ÐÓ°ÉÂÛ̳

Skip to main content

Combating ÐÓ°ÉÂÛ̳-19 ¨C Monoclonal Antibody Therapies to Optimize Patient Care

Date: Friday, May 7, 2021

Description: A discussion and overview of the monoclonal antibody therapy program sponsored by the US Department of Health and Human Services.

Authors:?

Anderson, Michael R., MD, MBA, FAAP
Senior Advisor, Office of the Assistant Secretary of Preparedness and Response (ASPR)
US Dept. of Health and Human Services?

Chuk, Meredith, MD, FAAP
Lead, ÐÓ°ÉÂÛ̳-19 Therapeutics Team Office of the Assistant Secretary of Preparedness and Response (ASPR)
US Dept. of Health and Human Services?

Dugan, Vivien, PhD
Lead, Strain Surveillance and Emerging Variants Team, Laboratory & Testing Task Force, ÐÓ°ÉÂÛ̳-19 Emergency Response Team CDC?

Edward, Adolphe, DrHA, MBA, MSHA
Chief Executive Officer,
El Centro Regional Medical Center
El Centro, CA?

Kapoor, Hema, MD SM, D(ABMM)
Senior Medical Director
Infectious Diseases & Immunology and Global Diagnostics Network
Quest Diagnostics, Secaucus, New Jersey?

Ramers, Christian B., MD, MPH, AAHIVS
Chief, Population Health and Director, Graduate Medical Education Family Health Centers of San Diego?

Date:
May 07, 2021